EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock

Elma J Peters iD, Joakim B Kunkel, Margriet Bogerd iD, Sanne Ten Berg iD, Marijke J C Timmermans, Ole K L Helgestad, Hanne B Ravn, Adriaan O Kraaijeveld, Luuk C Otterspoor iD, Krischan D Sjauw, Erik Lipšic, Annemarie E Engström und 4 weitere

European Heart Journal: Acute Cardiovascular Care · 2025

DOI: 10.1093/ehjacc/zuaf043 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Elma J Peters und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Heart Center, Amsterdam University Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Myocardial Infarction, Registries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS) is high, but a widely accepted tool for individual risk assessment is lacking. A reliable prediction model could assist in clinical decision-making, patient selection for clinical trials, and comparison of AMICS populations. Therefore, the aim of this study was to develop and externally validate a prediction model for 30-day mortality in AMICS patients. Methods and results This retrospective cohort study included patients from 2017 to 2021 (development cohort) and 2010–2017 (validation cohort). Patients with AMICS undergoing percutaneous coronary intervention in The Netherlands were identified using the Netherlands Heart Registration. International validation was performed in the Danish Retroshock registry. The main outcome was 30-day mortality. Among 2261 patients, the median age was 67 years [interquartile range (IQR) 58–75], and 1649 (73%) were male. The mortality rate at 30 days was 39% (n = 886). Significant predictors for mortality were: initial lactate, glucose, renal function, haemoglobin, age, blood pressure, heart rate, intubation prior to PCI, intervention in the left main coronary artery, and successful revascularization. The AUC of the initial model was 0.81 (0.79–0.83). The external validation cohort included 1393 patients with 1050 (75%) male and a median age of 67 years (IQR 59–75). The 30-day mortality rate was 49% (n = 680). The model showed good performance on the external validation with an AUC of 0.73 (0.70–0.76).

Conclusion

A prediction model was developed and externally validated using data from two large national registries. The model demonstrated good performance and is suitable for clinical decision-making and quality purposes in AMICS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicMyocardial InfarctionRegistriesHumansMaleFemaleAgedRetrospective StudiesRisk AssessmentMiddle AgedPercutaneous Coronary InterventionNetherlandsRisk FactorsSurvival RatePrognosis

Stichwörter der Autor:innen

Acute myocardial infarctionCardiogenic shockMortalityPrediction modelRisk prediction

Autor:innen und Institutionen

  • Department of Cardiology, Heart Center, Amsterdam University Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands.
  • Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Netherlands Heart Registration, Utrecht, The Netherlands.
  • Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Department of Cardiothoracic Anesthesia, Odense University Hospital, Odense, Denmark.
  • Department of Cardiology, Utrecht University Medical Center, Utrecht, The Netherlands.

ORCID-Profile: Elma J Peters, Margriet Bogerd, Sanne Ten Berg, Luuk C Otterspoor, Alexander P J Vlaar, José P S Henriques

Zitieren

APA

Peters, E. J., Kunkel, J. B., Bogerd, M., Ten Berg, S., Timmermans, M. J. C., Helgestad, O. K. L., Ravn, H. B., Kraaijeveld, A. O., Otterspoor, L. C., Sjauw, K. D., Lipšic, E., Engström, A. E., Vlaar, A. P. J., Hassager, C., Møller, J. E., & Henriques, J. P. S. (2025). Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuaf043

Vancouver

Peters EJ, Kunkel JB, Bogerd M, Ten Berg S, Timmermans MJC, Helgestad OKL, et al. Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuaf043

BibTeX
@article{Peters2025,
  author = {Peters, Elma J and Kunkel, Joakim B and Bogerd, Margriet and Ten Berg, Sanne and Timmermans, Marijke J C and Helgestad, Ole K L and Ravn, Hanne B and Kraaijeveld, Adriaan O and Otterspoor, Luuk C and Sjauw, Krischan D and Lipšic, Erik and Engström, Annemarie E and Vlaar, Alexander P J and Hassager, Christian and Møller, Jacob E and Henriques, José P S},
  title = {Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2025},
  doi = {10.1093/ehjacc/zuaf043}
}
Kostenlos starten →